3. Success Story
› Unique Strategy
“Target small market of rare diseases”
› Business Model
“High-Risk, High-Reward”
› Orphan Drug Act - 1983
› Innovative initial marketing strategy to save cost
› First big success - Ceredase
4. Problems Faced
› Possible failures
– Eg: Orphan Drug Act
› Failure to realize weaknesses
› Management too rigid
› Need to maintain total control
5. Recommendations
› Partnerships to reduce manufacturing and sales cost
› Increase focus on marketing
› Management should be flexible
› Explore new opportunities to adapt to market dynamics
› Leverage the brand name to diversify operation